Site Search
Search Results
New Survey: 1 in 10 Cancer Patients Has Been Impacted by Nation’s Drug Shortages with Significant Delays to Cancer Care
... the current issue as well as prevent future crises.” In addition to the impact of the current drug shortages, respondents were asked if biomarker testing, an increasingly important tool in cancer care, had changed the course of their treatment. An overwhelming majority of respondents (77%) who have had biomarker testing agreed that the results gave their provider valuable information that led to better treatment, with the same number (77%) of ...
New Paper Finds Barriers to Equitable Discovery and Implementation of Pharmacogenomic Testing in Cancer Care Despite its Power to Improve Patient Outcomes
... February 22, 2024 – A new paper released today in the Journal of Clinical Oncology finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and ... from them.” ACS CAN is working to improve access to PGx testing through its state advocacy work to expand insurance coverage of comprehensive biomarker testing, which includes PGx testing. Biomarker testing is a critical step toward accessing precision medicine, including targeted therapies; however, not all patients who could benefit ...
Hundreds of Cancer Patients, Survivors to Congress: Make Cancer a National Priority
... Illinois State Representative Mary Flowers is being honored for her long-time commitment to health issues, including increased access to biomarker cancer testing. ACS CAN’s Judicial Advocacy Initiative award, which recognizes attorneys who generously donate their services to the cancer fight, is ...
American Cancer Society and ACS CAN Statement on National Cancer Institute Director Stepping Down
... “Prior to joining NCI, his research on mitigating the toxic effects of chemotherapy and advance targeted treatments through the use of biomarker testing characterizes his personal commitment to reducing the devastating effects of the more than 200 diseases we call cancer. He has significant ...
CEO of the American Cancer Society and ACS CAN Announces Transition Plans
... cancer prevention and care. Notable policy wins include federal coverage for patient navigators, and state level wins to ensure access to biomarker testing. In addition to these achievements, a hallmark of Knudsen’s tenure at ACS was significant growth in strategic partnerships and ...
American Cancer Society and ACS CAN Statement: White House’s Cancer Moonshot National Cancer Plan
... such as the Breast & Cervical Cancer Early Detection Program and accelerate access to innovation through reimbursement strategies ( e.g. biomarker testing). No Untreatable Cancers: Investment in fundamental science produces effective new approaches to precision cancer treatment, particularly ...